BIOMARIN PHARMACEUTICAL INC
Ticker: 1048477
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY2026 | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 989.71+29.2% | 766.21-1.3% | 776.13-6.0% | 825.41+10.8% | 745.15-0.1% | 745.74+4.7% | 712.03+9.7% | 648.83 |
| Total Income | 989.71+29.2% | 766.21-1.3% | 776.13-6.0% | 825.41+10.8% | 745.15-0.1% | 745.74+4.7% | 712.03+9.7% | 648.83 |
| EXPENSES | ||||||||
| Expenditure | 878.79+38.1% | 636.57-22.6% | 822.83+50.0% | 548.52+5.2% | 521.25-17.5% | 631.85+6.8% | 591.58+5.6% | 560.37 |
| Tax | 16.62-53.4% | 35.68+707.2% | 4.42-92.3% | 57.34+9.4% | 52.40+84.8% | 28.36+13.6% | 24.96+47.8% | 16.89 |
| PROFIT | ||||||||
| PBT | 61.38-56.5% | 141.20+636.5% | -26.32-108.8% | 297.87+25.1% | 238.09+77.1% | 134.44+1.7% | 132.14+25.2% | 105.55 |
| Net Profit | 44.76-57.6% | 105.53+443.3% | -30.74-112.8% | 240.53+29.5% | 185.69+75.0% | 106.08-1.0% | 107.17+20.9% | 88.66 |
| KEY METRICS | ||||||||
| OPM % | 11.21%-5.71pp | 16.92%+22.94pp | -6.02%-39.56pp | 33.55%+3.50pp | 30.05%+14.78pp | 15.27%-1.65pp | 16.92%+3.28pp | 13.63% |
| NPM % | 4.52%-9.25pp | 13.77%+17.73pp | -3.96%-33.10pp | 29.14%+4.22pp | 24.92%+10.69pp | 14.22%-0.83pp | 15.05%+1.39pp | 13.66% |
| EPS | 0.23-58.2% | 0.55+443.8% | -0.16-112.8% | 1.25+28.9% | 0.97+73.2% | 0.56+0.0% | 0.56+19.1% | 0.47 |
Corporate Events
Board MeetingBMRN
20262Jun
Board Meeting
2026 Annual Meeting of Stockholders to elect directors, rati…
SEC Filing ↗